grouP O wholE blooD : storagE leSion impacT And infLammation

Recruiting now · Not applicable

Conditions studied: Blood Donation, Blood Platelets, Blood Donors, Inflammation, Transfusion

In brief

"Etablissement Français du Sang" (EFS) prepares labile blood products from blood donations that are separated by type (red blood cells, plasma and platelets). The "Centre de Transfusion Sanguine des Armées" (CTSA) produces an innovative labile blood product, LTO-WB, corresponding to group O leukocyte-free whole blood. The objective of the PEDESTAL EFS study is to compare the inflammatory and biological characteristics of blood products prepared by the EFS vs. the labile blood product prepared by the CTSA.

Key facts

Study ID

NCT06809010

Run by

Etablissement Français du Sang

People needed

30

Starts

2025-03-12

Expected to finish

2028-02-01

Last updated by the study team

2025-08-06

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Self-referred donors eligible for blood donation (whole blood and/or platelet/plasma apheresis), meeting the following inclusion criteria:
• Be in good health
• Weigh at least 50 kg
• Must be between 18 and 70 years of age for whole blood donation and between 18 and 65 years of age for plasma/platelet donation by apheresis.

You may not qualify if…

• Subjects ineligible to donate blood

Where it is running

• Maison du don de l'EFS Auvergne Rhônes-Alpes — Saint-Etienne, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.